Cancer Research: Funding Gap

Lord Allan of Hallam Excerpts

Monday 29th January 2024 Lords Chamber

[Viscount Camrose (Con)]

I am not familiar with this analysis, but it is very difficult to understand exactly how much is spent on cancer research, for the reason I gave earlier: so much cancer research is in areas adjacent or relevant to cancer without being specifically tagged as “cancer research”. For instance, in October 2023 the Prime Minister announced a new £100 million fund for the AI life sciences accelerator mission, which will have beneficial outcomes on cancer but is not tagged directly to cancer.

[Lord Allan of Hallam (LD)]

My Lords, I am sure the Minister receives regular representations from potential investors in medical research in the UK about what they need from the Department of Health and Social Care. Will he share with the House, and with his neighbour on the Front Bench, their key asks from the UK medical system and how he ensures a cross-government approach to entice in the maximum amount of investment?

[Viscount Camrose (Con)]

Indeed: it is so important to have not only a cross-government approach but a cross-sectoral approach. The Government work closely with academic, industry, charitable and other stakeholders. The crux of this is the healthcare missions of the Office for Life Sciences. The OLS cancer mission aims to show leadership in oncology innovation by developing further the approach first successfully used in the Vaccine Taskforce. Among other things, it has implemented the UK cancer research strategy forum, which brings together bodies of all kinds that are active in cancer research to ensure that they are effectively co-ordinated in today’s research and in future directions.